I'm More than My Tumor

The National Cancer Institute published their regular bulletin recently, and in it was an article on treating a person with lung cancer as the whole person. What struck me the most was the idea of fatigue so overwhelming with cancer, and yet so rarely dealt with.
Dr. Betty Ferrell, PhD explains, “Fatigue is really the existential crisis of cancer.” Symptoms like fatigue, pain, and other inevitable side effects of cancer treatment were dominating the lives of her patients, but she often found that clinicians and researchers were reluctant to address or even acknowledge this fact.
She’s not alone in her concern. The Institute of Medicine's report, Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs suggests a standard of care that incorporates psychosocial services into routine biomedical care.
This standard of care would include processes to:
• Identify psychosocial health needs;
• Connect patients and families to needed services;
• Support them in managing the illness;
• Coordinate the psychosocial and biomedical healthcare; and
• Follow-up on care delivery to evaluate the effectiveness of the services.
Another important facet of treating the whole patient is involving families. “It is families, not just people, who get cancer,” Dr. Ferrell explained. A cancer diagnosis often brings emotional and financial burdens that impact others in the family, which points to another vital and strategic aspect of palliative care.
For more information, visit the Cancer Recovery Community website at
http://www.cancerrecoverycommunity.org/. It is a not for profit organization, working to support people living with cancer. We encourage a holistic self management approach to health.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap